(Q34053682)

30 July 2017

title

The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review (English)

1 reference

30 July 2017

1 reference

1 reference

Y-L Wan

1

1 reference

30 July 2017

C Holland

series ordinal

2

1 reference

30 July 2017

publication date

23 October 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

14

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

622-632

1 reference

Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Theories of endometrial carcinogenesis: a multidisciplinary approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Endometrial hyperplasia and the risk of progression to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Intrauterine application of progestins in hormone replacement therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Benefit-risk assessment of the levonorgestrel intrauterine system in contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13697137.2011.579650

10.3109/13697137.2011.579650

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference